Daihan Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Daihan Pharmaceutical Co.,Ltd. has a market cap or net worth of KRW 157.88 billion. The enterprise value is 83.99 billion.

Market Cap	157.88B
Enterprise Value	83.99B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Daihan Pharmaceutical Co.,Ltd. has 5.88 million shares outstanding. The number of shares has decreased by -0.24% in one year.

Current Share Class	n/a
Shares Outstanding	5.88M
Shares Change (YoY)	-0.24%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.89%
Owned by Institutions (%)	46.71%
Float	4.00M

Valuation Ratios

The trailing PE ratio is 5.15.

PE Ratio	5.15
Forward PE	n/a
PS Ratio	0.78
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	10.12
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.87, with an EV/FCF ratio of 5.39.

EV / Earnings	2.74
EV / Sales	0.42
EV / EBITDA	1.87
EV / EBIT	2.26
EV / FCF	5.39

Financial Position

The company has a current ratio of 3.45

Current Ratio	3.45
Quick Ratio	2.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 11.97% and return on invested capital (ROIC) is 9.07%.

Return on Equity (ROE)	11.97%
Return on Assets (ROA)	7.74%
Return on Capital (ROIC)	9.07%
Revenue Per Employee	365.23M
Profits Per Employee	55.45M
Employee Count	553
Asset Turnover	0.67
Inventory Turnover	5.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.94%
50-Day Moving Average	25,922.00
200-Day Moving Average	27,333.00
Relative Strength Index (RSI)	57.42
Average Volume (20 Days)	8,552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daihan Pharmaceutical Co.,Ltd. had revenue of KRW 201.97 billion and earned 30.67 billion in profits. Earnings per share was 5,215.14.

Revenue	201.97B
Gross Profit	68.02B
Operating Income	37.18B
Pretax Income	39.45B
Net Income	30.67B
EBITDA	44.82B
EBIT	37.18B
Earnings Per Share (EPS)	5,215.14

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	73.89B
Total Debt	n/a
Net Cash	73.89B
Net Cash Per Share	12,566.22
Equity (Book Value)	268.33B
Book Value Per Share	45,635.20
Working Capital	94.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.01 billion and capital expenditures -21.42 billion, giving a free cash flow of 15.59 billion.

Operating Cash Flow	37.01B
Capital Expenditures	-21.42B
Free Cash Flow	15.59B
FCF Per Share	2,651.98

Full Cash Flow Statement

Margins

Gross margin is 33.68%, with operating and profit margins of 18.41% and 15.18%.

Gross Margin	33.68%
Operating Margin	18.41%
Pretax Margin	19.53%
Profit Margin	15.18%
EBITDA Margin	22.19%
EBIT Margin	18.41%
FCF Margin	7.72%

Dividends & Yields

This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 2.79%.

Dividend Per Share	750.00
Dividend Yield	2.79%
Dividend Growth (YoY)	15.38%
Years of Dividend Growth	2
Payout Ratio	14.12%
Buyback Yield	0.24%
Shareholder Yield	3.03%
Earnings Yield	19.42%
FCF Yield	9.88%

Dividend Details

Stock Splits

The last stock split was on April 29, 2002. It was a forward split with a ratio of 10.

Last Split Date	Apr 29, 2002
Split Type	Forward
Split Ratio	10

Scores

Daihan Pharmaceutical Co.,Ltd. has an Altman Z-Score of 4.74.

Altman Z-Score	4.74
Piotroski F-Score	n/a